Search

everythinglearnresearchcommunity

for

Search:↓

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Dupilumab may help regrow hair in people with severe alopecia.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Truncated hHb1 keratin may play a role in breast cancer cell transformation.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

A patient with complete hair loss regrew all her hair using tofacitinib.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.